Control and shRNA-TTN-AS1-transfected RBE cells were incubated with recombinant human HGF protein in the presence or absence of tivantinib, a c-Met inhibitor and an anti-cancer drug used in CCA clinical trial28. This evidence concerns the gene MET and cholangiocarcinoma.